Updated Jul 16, 2026 · Last SEC filing 2026-06-29
Passage BIO, Inc. (PASG) has filed 7 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-29. 6 Form 8-K material event filings were reported by PASG in the last 90 days. InsiderAlpha tracks every PASG SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001787297 |
|---|
| Form 4 filings (90d) | 7 |
|---|---|
| Form 8-K filings (90d) | 6 |
| Latest Form 4 filing | 2026-06-29 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner | P — Open-market purchase | 50.1K | $4.12 | $206K | SEC | |
| Chou William | PRESIDENT AND CEO | M — Option exercise | 10.0K | — | — | SEC | |
| Borthwick Kathleen | CFO | S — Open-market sale | 2.1K | $18.44 | $38K | SEC | |
| Borthwick Kathleen | CFO | M — Option exercise | 5.0K | — | — | SEC | |
| Chou William | PRESIDENT AND CEO | S — Open-market sale | 4.1K | $18.44 | $75K | SEC | |
| Lynx1 Capital Management LP | 10% Owner | P — Open-market purchase | 11.9K | $6.99 | $83K | SEC | |
| Lynx1 Capital Management LP | 10% Owner | P — Open-market purchase | 19.8K | $6.99 | $138K | SEC | |
| Lynx1 Capital Management LP | 10% Owner | P — Open-market purchase | 325 | $6.96 | $2K | SEC | |
| Lynx1 Capital Management LP | 10% Owner | P — Open-market purchase | 66.4K | $5.71 | $379K | SEC | |
| Lynx1 Capital Management LP | 10% Owner | P — Open-market purchase | 49.3K | $5.74 | $283K | SEC | |
| Lynx1 Capital Management LP | 10% Owner | P — Open-market purchase | 13.1K | $5.44 | $71K | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | S — Open-market sale | 213.3K | $0.33 | $70K | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | S — Open-market sale | 138.8K | $0.33 | $46K | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | S — Open-market sale | 231.6K | $0.35 | $81K | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | S — Open-market sale | 68.2K | $0.32 | $22K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Passage BIO, Inc. (PASG). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Kapadia Sandip | 1 | — |
| Lynx1 Capital Management LP | 1 | $206K |
| Countouriotis Athena | 1 | — |
| GOWEN MAXINE | 1 | — |
| Kassberg Thomas Richard | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PASG insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live PASG dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.